Press Release

Auxogyn and Fertility Authority Announce Merger

March 17, 2015

Palo Alto – March 17, 2015 – Cooley is advising Auxogyn, Inc. on its merger with Fertility Authority, LLC. The combined company will be the first to provide fertility patients with easy access under one roof to high-quality doctors, price transparency and financing, extraordinary clinical expertise and proprietary clinical solutions. The company's headquarters will be located in New York with operations in Menlo Park, CA.

By leveraging Fertility Authority's online patient-matching platform, the combined entity will enable more consumers to become educated about the benefits of single embryo transfer and about Auxogyn's Eeva™ Test. The Eeva™ Test is a first-in-class, FDA-cleared, non-invasive prognostic test that uses time-lapse imaging and statistical modeling to assess consistently and objectively early embryo development milestones with minimal disturbance to the embryo during incubation. The proprietary, automated Eeva Test helps IVF clinicians optimize their treatment for patients undergoing IVF procedures. Auxogyn received a CE mark for the Eeva™ Test in July 2012, and FDA clearance in June 2014.

The team advising Auxogyn includes partner and head of Cooley's medical device practice, Mark Weeks, partner Danielle Naftulin and associates Rose Standifer and Hannah Minkevitch.

Critical support on the transaction was provided by partner Renee Deming (compensation and benefits); partner Mark Windfeld-Hansen (tax); partner Josh Mates (employment and labor); partner Anne Peck (trademark); partner Wendy Goldstein, special counsel Phil Mitchell and associates Leah Roffman and Stephanie Cason (health care and life sciences regulatory); associate Rebecca Teterud (credit finance); associate Alyson Fuller (patent counseling and prosecution); and associate Bryan Berman (technology transactions).

About Cooley LLP

Cooley's lawyers solve legal issues for entrepreneurs, investors, financial institutions and established companies. Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, often where innovation meets the law.

Cooley has 850 lawyers across 12 offices in the United States, China and Europe.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.